These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 3491222)

  • 1. A growing industry and menace: makeshift laboratory's designer drugs.
    Ziporyn T
    JAMA; 1986 Dec; 256(22):3061-3. PubMed ID: 3491222
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): one designer drug and serendipity.
    Weingarten HL
    J Forensic Sci; 1988 Mar; 33(2):588-95. PubMed ID: 3259617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer drugs--the "whats" and the "whys".
    Chesher G
    Med J Aust; 1990 Aug; 153(3):157-61. PubMed ID: 2377119
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxin-induced parkinsonism: recent developments.
    Fruncillo RJ
    Am Fam Physician; 1986 Mar; 33(3):251-4. PubMed ID: 3485368
    [No Abstract]   [Full Text] [Related]  

  • 5. Street-drug contaminant causing parkinsonism.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jun; 33(24):351-2. PubMed ID: 6427583
    [No Abstract]   [Full Text] [Related]  

  • 6. Leads from the MMWR. Street-drug contaminant causing parkinsonism.
    JAMA; 1984 Jul; 252(3):331. PubMed ID: 6610772
    [No Abstract]   [Full Text] [Related]  

  • 7. Street drugs yield primate Parkinson's model.
    Blume E
    JAMA; 1983 Jul; 250(1):13-4. PubMed ID: 6602228
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Designer drugs'. A problem in clinical toxicology.
    Buchanan JF; Brown CR
    Med Toxicol Adverse Drug Exp; 1988; 3(1):1-17. PubMed ID: 3285124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The neurotoxic effect of MPTP and its mechanisms].
    Xu XJ
    Sheng Li Ke Xue Jin Zhan; 1988 Oct; 19(4):310-4. PubMed ID: 3074503
    [No Abstract]   [Full Text] [Related]  

  • 10. Movement disorders and substance abuse.
    Lopez W; Jeste DV
    Psychiatr Serv; 1997 May; 48(5):634-6. PubMed ID: 9144817
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Designer Drug' Enforcement Act seeks to attack problem at source.
    Hagerty C
    Am Pharm; 1985 Oct; NS25(10):10-1. PubMed ID: 4061277
    [No Abstract]   [Full Text] [Related]  

  • 12. [MPTP and Parkinson's disease].
    Imai H
    No To Shinkei; 1988 Nov; 40(11):1011-24. PubMed ID: 3064783
    [No Abstract]   [Full Text] [Related]  

  • 13. Cooking up solutions to a cooked up menace: responses to methamphetamine in a federal system.
    Harv Law Rev; 2006 Jun; 119(8):2508-29. PubMed ID: 16827221
    [No Abstract]   [Full Text] [Related]  

  • 14. New psychoactive substances: issues about the new approach from New Zealand government.
    von Diemen L
    Addiction; 2014 Oct; 109(10):1588-9. PubMed ID: 25163704
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mammography--methyl-phenyl-tetrahydropyridine].
    Shibusawa K
    Kango; 1985 Aug; 37(9):74-5. PubMed ID: 3879515
    [No Abstract]   [Full Text] [Related]  

  • 16. The bogus drug: Three methyl & alpha methyl fentanyl sold as "China White".
    Ayres WA; Starsiak MJ; Sokolay P
    J Psychoactive Drugs; 1981; 13(1):91-3. PubMed ID: 7277090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental model of Parkinson disease induced by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Renkawek K
    Neuropatol Pol; 1986; 24(1):1-8. PubMed ID: 3489205
    [No Abstract]   [Full Text] [Related]  

  • 18. View from the Nation's Capital.
    Appler WD
    J Clin Psychopharmacol; 1985 Dec; 5(6):350-2. PubMed ID: 4067003
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Chiba K; Kubota E; Miyakawa T; Kato Y; Ishizaki T
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1108-15. PubMed ID: 3262153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.